Glp-2 drugs list
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Comprehensive List of GLP-1 Receptor Agonists for Type 2 Diabetes
Introduction to GLP-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications used to manage type 2 diabetes. These drugs mimic the action of the GLP-1 hormone, which increases insulin secretion, inhibits glucagon release, and slows gastric emptying, thereby helping to control blood sugar levels. They are also known for their cardiovascular and renal benefits, making them a valuable option for patients with type 2 diabetes who are at risk of cardiovascular and kidney diseases .
List of GLP-1 Receptor Agonists
1. Exenatide
Exenatide is one of the first GLP-1 receptor agonists introduced to the market. It is available in two formulations: a twice-daily injection (Byetta) and a once-weekly injection (Bydureon). Exenatide has been shown to improve glycemic control and promote weight loss in patients with type 2 diabetes.
2. Liraglutide
Liraglutide (Victoza) is a once-daily injection that has demonstrated significant benefits in reducing blood sugar levels and body weight. Additionally, liraglutide has been associated with a reduction in cardiovascular events, making it a preferred choice for patients with a high risk of cardiovascular disease .
3. Dulaglutide
Dulaglutide (Trulicity) is a once-weekly injection that offers convenience and efficacy in managing blood glucose levels. It has also been shown to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes.
4. Semaglutide
Semaglutide is available in two forms: a once-weekly injection (Ozempic) and an oral tablet (Rybelsus). Semaglutide has been effective in lowering HbA1c levels and promoting weight loss. It also provides cardiovascular benefits, similar to other GLP-1 receptor agonists .
5. Lixisenatide
Lixisenatide (Adlyxin) is a once-daily injection that helps improve glycemic control in patients with type 2 diabetes. It is often used in combination with other antidiabetic medications to enhance its efficacy.
6. Albiglutide
Albiglutide (Tanzeum) is a once-weekly injection that has been shown to improve blood sugar control and support weight loss. However, it is less commonly used compared to other GLP-1 receptor agonists.
Benefits and Considerations
Cardiovascular and Renal Benefits
GLP-1 receptor agonists not only help in managing blood glucose levels but also offer significant cardiovascular and renal benefits. Studies have shown that these drugs can reduce the risk of cardiovascular events, all-cause mortality, and the progression of renal disease in patients with type 2 diabetes .
Side Effects
While GLP-1 receptor agonists are generally well-tolerated, they can cause gastrointestinal side effects such as nausea, vomiting, and diarrhea. These side effects are usually mild and tend to decrease over time.
Conclusion
GLP-1 receptor agonists are a crucial component in the management of type 2 diabetes, offering both glycemic control and cardiovascular benefits. The list of GLP-1 receptor agonists includes exenatide, liraglutide, dulaglutide, semaglutide, lixisenatide, and albiglutide, each with unique dosing schedules and benefits. These medications provide a valuable option for patients, particularly those at high risk of cardiovascular and renal complications.
Sources and full results
Most relevant research papers on this topic